An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to users administering substances of unknown origin.
Several experts stated the demand for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison.
Service Response and Content Removal
Based on TikTok, the service has removed violative material and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the platform secure and investing in strengthening compliance measures.
Online Marketplace Operations
Investigations also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, filled with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at home.
Within minutes of joining one group, a seller shared WhatsApp details, where most transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience.
Item Information and Costs
Inside these communities, messages show dark colored parcels with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for Telegram said it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious medical dangers”.
